At present, the global cardiovascular drugs marketing total scale surpasses 100 billion USD, which equals to 16%-17% of the total international pharmaceutical market turnover. Among them, usage of renin angiotensin drugs increased by 30.3%, Vasoprotectant increased by 58.4%. The rapidly increasing of cardiovascular disease patients’ number brings huge market space for the cardiovascular drugs.

Cardiovascular disease is one of the diseases with high death rate. There are 17.5 million people who die of cardiovascular disease every year worldwide. The death number of cardiovascular disease will be expected to 25 million in the year of 2020. Thus, it becomes an increasingly urgent big public health problem.

To BELTROAD, we not only advocate people protecting cardiovascular from their own habits, but also providing the best products series to more patients by the lowest cost.